FDA Program Cuts Loom If ‘Cures’ Bill Isn’t Fully Funded, Ostroff Warns

FDA’s acting commissioner says agency may have to ‘stop doing something else’ in order to cover the new responsibilities envisioned in the Cures legislation.

Acting FDA Commissioner Stephen Ostroff remains optimistic that the House and Senate will fill the funding gap in the 21st Century Cures legislation and not force cuts to other programs.

The bill, intended to help get innovative medical products to patients faster, has cleared the Energy & Commerce Committee and...

More from United States

More from North America